Etamycin as a NovelMycobacterium abscessusInhibitor
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hanh, Bui Thi Bich | - |
dc.contributor.author | Kim, Tae Ho | - |
dc.contributor.author | Park, June-Woo | - |
dc.contributor.author | Lee, Da-Gyum | - |
dc.contributor.author | Kim, Jae-Sung | - |
dc.contributor.author | Du, Young Eun | - |
dc.contributor.author | Yang, Chul-Su | - |
dc.contributor.author | Oh, Dong-Chan | - |
dc.contributor.author | Jang, Jichan | - |
dc.date.accessioned | 2021-06-22T06:00:18Z | - |
dc.date.available | 2021-06-22T06:00:18Z | - |
dc.date.issued | 2020-09 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.issn | 1422-0067 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/921 | - |
dc.description.abstract | The increase in drug-resistantMycobacterium abscessus, which has become resistant to existing standard-of-care agents, is a major concern, and new antibacterial agents are strongly needed. In this study, we introduced etamycin that showed an excellent activity againstM. abscessus. We found that etamycin significantly inhibited the growth ofM. abscessuswild-type strain, three subspecies, and clinical isolates in vitro and inhibited the growth ofM. abscessusthat resides in macrophages without cytotoxicity. Furthermore, the in vivo efficacy of etamycin in the zebrafish (Danio rerio) infection model was greater than that of clarithromycin, which is recommended as the core agent for treatingM. abscessusinfections. Thus, we concluded that etamycin is a potential anti-M. abscessuscandidate for further development as a clinical drug candidate. | - |
dc.format.extent | 14 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
dc.title | Etamycin as a NovelMycobacterium abscessusInhibitor | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/ijms21186908 | - |
dc.identifier.scopusid | 2-s2.0-85091406516 | - |
dc.identifier.wosid | 000579930400001 | - |
dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, v.21, no.18, pp 1 - 14 | - |
dc.citation.title | International Journal of Molecular Sciences | - |
dc.citation.volume | 21 | - |
dc.citation.number | 18 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 14 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | MYCOBACTERIUM-ABSCESSUS | - |
dc.subject.keywordAuthor | Mycobacterium abscessus | - |
dc.subject.keywordAuthor | drug resistance | - |
dc.subject.keywordAuthor | novel drug discovery | - |
dc.identifier.url | https://www.mdpi.com/1422-0067/21/18/6908 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.